Dr. Schaffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2019
- University of RochesterResidency, Internal Medicine, 2013 - 2016
- University of Virginia School of MedicineClass of 2013
Certifications & Licensure
- TN State Medical License 2019 - 2026
- NY State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 80 citationsToxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer SurvivorsChunkit Fung, Paul C. Dinh, Shirin Ardeshir-Rouhani-Fard, Kerry Schaffer, Sophie D. Fosså
Advances in Urology. 2018-02-18 - 41 citationsSingle cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.Hong Yuen Wong, Quanhu Sheng, Amanda B Hesterberg, Sarah Croessmann, Brenda L Rios
Nature Communications. 2022-10-13 - 42 citationsSystematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.Kerry Schaffer, Narmadha Panneerselvam, Kah Poh Loh, Rachel S. Herrmann, Ian R. Kleckner
Journal of the National Comprehensive Cancer Network. 2019-01-01
Press Mentions
- Polygenic Risk Score Does Not Improve Prediction of Aggressive Prostate CancerMarch 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: